Objective. To develop a multi-attribute outcome measure for children with asthma that allows for the calculation of qualityadjusted life years in cost-effectiveness studies and can also be used to assign preference weights to asthma-symptom-free days.
The prevalence of asthma in children and young adults in the United States has increased since 1980, reaching estimates as high as 10.1% in some regions of the country [1, 2] . Asthma in these patients leads to increased school absences, health services utilization, and mortality, placing substantial burden on both patients and their families [3] [4] [5] . In addition, asthma symptoms can impart significant limitations on physical activities and decrease the quality of life in children with asthma [6] . Importantly, asthma symptoms are often episodic and can vary in severity and duration. Therefore, when assessing the effectiveness or cost-effectiveness of interventions for the treatment of asthma it is important to include measures that incorporate both the frequency and duration of asthma symptoms.
The asthma-symptom-free day, used to quantify the number of days a patient is free from asthma symptoms, is a disease-specific symptom measure that includes the presence and duration of asthma symptoms [7] . The asthma-symptomfree day has been advocated by a national group in the United States as the primary outcome measure for cost-effectiveness studies in asthma [8] . However, the use of disease-specific measures of effectiveness in cost-effectiveness ratios makes it difficult to compare the relative value of interventions across disease states. The US Panel on Cost-Effectiveness in Health and Medicine recommended that health outcomes in costeffectiveness studies be measured in quality-adjusted life years (QALYs) [9] . QALYs are calculated as a product of the duration of a health state and the preference weight or utility for the health state and are measured on an interval scale from zero (death) to one (perfect health) [9] .
Importantly, generic measures used to calculate QALYs may be too complicated for children with asthma or may not be sensitive to changes in health status in children with asthma [10] . At the same time, many asthma-specific measures, which are sensitive to changes in health status, are not designed to measure QALYs [7] . There is no single instrument that includes a means of calculating utilities, is sensitive to changes in asthma health status, and provides utility weights for asthma-symptomfree days. Recently, Revicki and colleagues [11] partially addressed this gap by developing a preference-based symptom measure, the Asthma Symptom Utility Index, which was intended to provide scores on a zero to one scale and be sensitive to changes in asthma. However, the response scale in their instrument combines the duration of symptoms with the severity of symptoms, making it impossible to identify the number of days during which a patient experienced a given level of severity of symptoms during a 2-week period.
Therefore, the objective of this research was to develop a multi-attribute, asthma-specific outcome measure for children with asthma that allows for the calculation of QALYs in cost-effectiveness studies and the number of asthma-symptom-free days. This new measure, called the Pediatric Asthma Health Outcome Measure (PAHOM), can be used to assess the daily impact of asthma with a health classification system (i.e. the PAHOM calendar) and assign preference weights to various asthma-related health states based on community preferences. More importantly, the new measure can be used to monitor the quality of health care in asthma in an ongoing standardized way, provide information about quality to caregivers and decision-makers to assist them in choosing between different managed-care plans, and provide further incentive for quality improvement.
Methods
In developing the PAHOM, we undertook several distinct steps. The first step was the selection of the health attributes (and thus defining the health states) that would make up the calendar. The second step was to estimate the preference weight for each of the health states. Finally, we tested the PAHOM in a group of children with asthma recruited for enrollment in an environmental intervention study.
Development of the PAHOM calendar
Selection of health attributes. We first reviewed available asthmaspecific health outcome measures to inform our selection of health attributes for the new measure (Table 1) [12] [13] [14] [15] [16] [17] . Although the six questionnaires labeled each attribute slightly differently, five of them included a symptom attribute, an activity attribute, and an emotion attribute, according to the Table 2 ). The symptom attribute was divided into three levels: free from symptoms (s1), having moderate breathing problems (s2), and having severe breathing problems (s3). The emotion attribute was divided into two levels: absence (e1) and presence (e2) of emotional problems. The activity attribute was divided into two levels: absence (a1) and presence (a2) of activity problems. The 3 × 2 × 2 classification system results in 12 unique health states. However, we removed the two health states (s3, e1, a1) and (s3, e2, a1) because we believed children hospitalized due to severe breathing problems would experience activity limitations. Therefore, the classification system contains 10 valid health states. Questions from current asthma-specific health outcome measures were used as an initial source in developing questions for the PAHOM calendar (Table 1 ). Subsequently, we asked a broad range of experts in the field of asthma research, including pediatricians, psychologists, psychiatrists, sociologists, and economists, to describe each attribute, and conducted in-depth interviews with eight people (four children and four adults) with asthma. The PAHOM calendar and questions are shown in the Appendix.
Recall period. The 'best' recall period selected for any selfreported measure is the amount of time that maximizes the duration of the recall period and still provides accurate and valid responses. Previous research showed a gap between the perception of children with asthma and that of their caregivers on how asthma impacts children's quality of life [18] . One of several potential explanations for the gap was that children are able to accurately recall their health status over a shorter period of time than adults. Therefore, we limited the recall period of the PAHOM calendar to 7 days.
We pre-tested the recall period of the calendar, as well as the wording of the questions, on five children with asthma between 7 and 13 years old. The interviewer began by pointing to the current day on the calendar, and then marked the 7 previous days to show which days to complete. Four children could remember their health problems during the previous 7 days, while one child could remember 6 out of 7 days.
Derivation of preference weights for health states
Preference weight survey. A total of 124 adults were recruited from Seattle, Washington using random digit dialing. The inclusion criteria were: (i) able to read, understand, and speak English; (ii) at least 18 years old; (iii) able to write without any aids; and (iv) able to see without aids other than eyeglasses. The University of Washington Human Subjects Division approved the protocol for the survey and written informed consent was obtained from each person. Both visual analog scale (VAS) and standard gamble (SG) elicitation techniques were used to estimate preference weights. The adult respondents were asked to respond for children, because a child's preference weights would be used to measure the effectiveness of pediatric programs. Torrance and colleagues [19, 20] have successfully used this technique to derive a utility index for children.
Respondents were asked to complete the VAS section first. The task for respondents was to rank health states relative to each other and relative to anchor states ('perfect health' and 'death') on a 15-centimeter line. Upon the completion of the VAS section, respondents were instructed to answer the SG questions. Each SG question used in the survey had two scenarios. One was the certain scenario in which a child would live with a health problem, such as moderate symptoms, for the rest of his or her life. The other was the uncertain scenario in which a treatment for the health problem had two possible outcomes (i.e. success or failure). A successful treatment would enable the child to live with perfect health for the rest of his or her life. To address the framing effect of the SG questions, respondents were asked each SG question from two different perspectives [21] [22] [23] [24] [25] . Firstly, the respondents were asked how high the probability of attaining perfect health would have to be for them to choose the treatment. 
Symptoms 1
The child does not have any breathing problems. 2 The child has tightness in the chest, shortness of breath, coughing, and wheezing, which is breathing hard with a whistling, breathy sound. The child may also awaken during the night because of the breathing problem. 3 The child has a severe breathing problem and must go to the hospital or visit a doctor. Emotion 1 The child is happy. 2
The child sometimes feels different and left out, for example, the way one might feel after missing a party that friends went to or a ball game. The child usually bounces back in a few hours, however, and would not need to see a doctor or mental health professional. Activity 1 The child does not have any problems in performing normal activities and exercise. 2 The child cannot do normal activities and exercise like playing sports and games, playing with friends and pets, or participating in school activities.
Then, they were asked how low the probability of dying would have to be for them to choose the treatment. The average of these two answers was used in the analysis [26] . Data analyses. To estimate the preference weights for the health states of the PAHOM, the mean and standard deviation (SD) of adults' responses to each question were calculated. However, due to the cognitive burden with the SG, not all health states were included in the SG questions. Importantly, the VAS is considered a measure of value rather than preference and the SG is the only technique that produces von Neumann-Morgenstern utilities [20] . The SG utilities are valid by implication if the basic assumptions of expected utility theory are accepted [19] . It is also believed that SG utilities are gathered in a setting that mirrors many clinical decisions where patients or caregivers must make choices under conditions of uncertainty [19] . Thus, utilizing data on preference weights for health states measured by both VAS and SG questions [i.e. (s2, e1, a1), (s1, e2, a1), (s1, e1, a2), (s2, e2, a2) , and (s3, e2, a2)], we converted VAS values to SG utilities for all health states through a relative risk attitude equation. Following previous studies, the relative risk attitude equation was fit based on a power function: (1-u) = (1-v) α where α is estimated from measurement of v (i.e. value) and u (i.e. utility) on the same health states [20, 27] . α was estimated with a restricted least squares regression using the five pairs of mean values and utilities for the aforementioned health states.
An example of the application of the PAHOM
The PAHOM calendar was used as part of the baseline assessment of the Seattle-King County Healthy Homes project [26] . The Healthy Homes project is a randomized, controlled trial to test an environmental intervention to reduce exposure to asthma triggers. Children were recruited for the trial through several channels, including community clinics, emergency departments, and hospitals.
Inclusion criteria for the Healthy Homes study included: (i) living in King County, Washington; (ii) having healthprovider-diagnosed asthma of at least mild, persistent severity, (iii) age 4-12 years old, and (iv) from a household with an income <200% of the federal poverty level. Additionally, we only administered the PAHOM to children from 7 to 12 years old. Although over 200 children enrolled in the Healthy Homes project, the PAHOM calendar was administered to only 72 children between July 1999 and October 2000 due to difficulties in scheduling interviews with the other children [26] .
The PAHOM calendar was administered in person and patients were instructed to complete the PAHOM calendar based on the 7 days prior to their visit. The 7-day averages for VAS value and converted SG utility corresponding to health states derived based on the calendar were the PAHOM scores.
Finally, we demonstrated how the PAHOM could convert results of an asthma-symptom-free day measure to QALYs. According to the asthma-symptom-free day measure, the PAHOM health states (s2, e1, a1), (s2, e2, a1), (s2, e1, a2), and (s2, e2, a2) will all be considered the health state in which patients have moderate asthma symptoms regardless of the patients' scores on the emotion or activity attribute; the PAHOM health states (s3, e2, a2) and (s3, e1, a2) will be considered the health state in which patients have severe asthma symptoms; and the remaining PAHOM health states [except for (s1, e1, a1)] will all be considered the health state in which patients have mild asthma symptoms. Ideally, the preference weights for days with mild, moderate, and severe asthma symptoms can be derived by averaging the preference weights of the PAHOM health states in which patients have the same severity level of asthma symptoms. One could overestimate the QALYs in a cost-effectiveness analysis by assigning the preference weights of (s1, e1, a1), (s2, e1, a1), and (s3, e1, a2) to mild, moderate, and severe asthma symptom states, respectively.
Results

PAHOM preference weights
A total of 114 adults completed the survey. Of these adults, 58% were female, the mean age was 38 (±15.4) years, 72% were white, 21% were Asian, and 38% had children. In regard to asthma, 11% of the respondents reported that they had asthma and 11% reported having a family member with asthma. Thirteen respondents gave inconsistent responses to the SG questions [e.g. rated utility of (s1, e2, a1) < (s1, e2, a2)] while 20 provided inconsistent responses to VAS questions. Only 87 respondents provided consistent responses to both SG and VAS questions. The mean VAS values of all eight health states and mean SG utilities of five health states in addition to perfect health (i.e. 1) and death (i.e. 0) are reported in Table 3 . SG utilities were greater than VAS values for the same health states. The mean VAS value and SG utility of a health state with only moderate symptoms (s2, e1, a1) were higher than a health state with only an emotional problem (s1, e2, a1) (0.79 versus 0.66 and 0.93 versus 0.90, respectively) and higher than a health state with only an activity limitation (s1, e1, a2) (0.79 versus 0.60 and 0.93 versus 0.87, respectively). The lowest mean value and utility were 0.03 and 0.65 for the worst health state [s3, e2, a2]. The risk attitude coefficient α of the relative risk attitude equation was 2.05. The converted SG utility obtained by transforming the VAS value with the relative risk attitude equation for each health state in the PAHOM is reported in Table 3 .
Application of the PAHOM
Baseline characteristics of the 72 children who completed the PAHOM calendar are listed in Table 4 . Fifty-nine of the 72 children (82%) reported having mild/moderate asthma symptoms for at least 1 day in the previous week. Using the PAHOM calendar, children reported that they were free from asthma symptoms on 57% of days during the previous week, which equates to an average of 3.99 asthma-symptom-free days per child over the previous 7 days. Caretakers, using a symptom-free day measure at the screening interview, reported that on 48% of days during the previous week the child was free from asthma symptoms (average of 3.36 asthma-symptom-free days).
Over the 7-day response period, the most frequent health state (38%) was (s1, e1, a1), where no health problems were present (Table 5) . Symptom-free days with an emotional problem, activity limitation, or both occurred on 19% of the days. Children reported that a moderate breathing problem occurred on 38% of the days, and on 22% of the days where the moderate breathing problem occurred there was also an accompanying emotional problem, activity limitation, or both. A severe breathing problem was reported on 5% of the days. The mean PAHOM scores of these children were 0.70 and 0.83 when measured by VAS value and converted SG utility, respectively.
The derived VAS value and converted SG utility for days with mild symptoms of an asthma-symptom-free day measure were 0.55 and 0.79, respectively; for days with moderate symptoms the corresponding scores were 0.49 and 0.70, respectively; and for days with severe symptoms the scores were 0.16 and 0.28, respectively. The mean scores of the same pediatric asthma patients were 0.68 and 0.81, respectively, when measured with these preference weights.
Discussion
We developed an asthma-specific multi-attribute health state classification system (the PAHOM) with several goals: to monitor the quality of health care in asthma in an ongoing standardized way; to provide information about quality to caregivers and decision-makers to assist them in choosing between different managed-care plans; and to provide further incentive for quality improvement. Specifically, the PAHOM can be used in asthma studies to estimate preference weights. These preference weights can then be applied to estimate QALYs of patients with asthma. In this paper we described the development process of the instrument and initial use of the instrument in a small sample of asthmatic children participating in a clinical trial. Unlike many disease-specific measures such as the symptom-free day or even the Asthma Symptom Utility Index, the PAHOM includes measures of activity and emotion domains that are important factors when considering overall health-related quality of life. The inclusion of these domains makes the PAHOM potentially a more sensitive instrument when assessing the overall impact of asthma. We provide preference weights for the PAHOM that can be used in calculating cost:QALY ratios and yet the instrument also allows for the calculation of cost-effectiveness ratios using symptom-free days as the denominator. Thus, the instrument meets recommendations from both the US Panel on Cost-Effectiveness in Health and Medicine [9] and the National Asthma Education and Prevention Program Working Group on Cost-Effectiveness in Asthma [8] .
The PAHOM appears to be a more comprehensive assessment tool than the Asthma Symptom Utility Index, which focused entirely on asthma symptoms. The developers of the Asthma Symptom Utility Index note that the instrument is not intended to be used to calculate QALYs but is instead to be used to assess the impact of symptoms [11] , whereas our goal was to develop a multi-attribute instrument that included more than a symptom domain and could be used in cost-effectiveness studies for the estimation of QALYs. Even with the different goals, there are similarities between the instruments: they are both scored on a zero to one scale and use SG questions to generate health state utilities. When comparing results, the estimates for mild/ moderate asthma symptoms from both measures appear to be within the same range. For example, a health state with moderate severity of coughing for 1-3 days has an Asthma Symptom Utility Index score of 0.92, and the one with mild severity of both coughing and wheezing for 3 days has an Asthma Symptom Utility Index score of 0.94, while the converted SG utility for one of the similar health states in the PAHOM is 0.96 [i.e. (s2, e1, a1) ].
The face validity of the PAHOM was supported by some evidence from the published literature. For example, Feeny et al. [28] reported mean (standard deviation) SG scores of three hypothetical asthma health states: 0.87 (0.10) for mild state; 0.71 (0.15) for moderate state; and 0.57 (0.17) for severe state. Based on converted SG utilities of the PAHOM, the derived utilities for mild, moderate, and severe asthma symptom health states were 0.79, 0.70, and 0.28, respectively. Both utilities for mild and moderate states based on the PAHOM appeared to be within or close to reasonable confidence intervals of Feeny and colleagues' estimates. Feeny et al. [28] also reported that the mean overall Health Utilities Index Mark 2 utility score was 0.93 at baseline for those whose asthma did not change during the study, and 0.87 for those whose asthma changed during the study. The mean converted SG utility at baseline for children in the Healthy Homes study was 0.83, which was reasonable since these children needed to have mild or moderate symptoms to have been enrolled in the study.
Although there was a concern about whether children can understand the temporal response scale used by the PAHOM calendar, the children to whom the PAHOM calendar was administered in the Healthy Homes project were all able to complete the calendar. Unlike most current health outcome measures, the PAHOM provides a calendar as a visual aid to help children recall their health states from the last 7 days. We chose a 7-day recall period in the hope of increasing the accuracy of responses from pediatric patients, but we did so realizing that the limited time period may result in missing bouts of asthma exacerbations. However, this is a limitation of any instrument that asks patients to recall their health status over a discrete period of time prior to their visit. As time periods are lengthened, more of the variability in the health state may be picked up, but at the same time the validity of the responses becomes more questionable. Thus, we believed that using a 7-day recall period would provide us with the most valid and accurate estimates of health states in this young population. Future asthma studies can easily adapt the PAHOM as a daily diary in order to overcome the aforementioned limitation.
There are several other limitations in the current study. Firstly, we have yet to evaluate the measurement properties of the instrument. Secondly, the limited number of levels included in each attribute might compromise the sensitivity of the PAHOM calendar to changes in health status. However, more levels would increase the complexity of the measure and the response burden to children and thus reduce the usefulness of the measure. Thirdly, the choice of attributes and levels may not encompass all of the possible scenarios, but we feel this simple, easy-to-use instrument captures the important aspects of asthma in children. Further evidence is needed to ensure that the emotion and activity attributes included in the PAHOM are truly more independent of symptoms than are other emotional problems (e.g. frustration, irritation) and activity limitations (e.g. walking one block, climbing stairs) commonly included in other asthma-specific outcome measures. Fourthly, there might be a gap between the preferences of children and those of adults. QALYs gained that are measured by applying the adults' SG utilities to the health states of children might not reflect the true value of the interventions. Fifthly, it is worth noting that there is a large discrepancy between utilities measured using SG and the relative risk attitude equation for health states (s2, e2, a2) and (s3, e2, a2). This might indicate that the validity of the relative risk attitude equation warrants further testing. Finally, as with any multi-attribute preference weight system we need to investigate the generalizability of the preference weights to determine whether there are differences based on socioeconomic status, race, or other factors.
